MMedication Read More FDA Approves Mannkind’s At-Home Treatment Option for Heart Failure or Kidney DiseaseJuly 28, 2026 Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Mannkind…
MMedication Read More Cingulate Receives Complete Response Letter from FDA for CTx-1301June 5, 2026 Cingulate Inc. No Clinical Safety or Efficacy Concerns Currently Identified Agency Feedback Primarily Focused on CMC-Related RequestsCompany Plans Prompt…
MMedication Read More Praxis Precision Medicines Announces FDA Acceptance and Priority Review of New Drug Application for Relutrigine in Patients with SCN2A and SCN8A DEEsMarch 31, 2026 Praxis Precision Medicines, Inc. FDA assigned PDUFA target action date of September 27, 2026 BOSTON, March 30, 2026…
HHealth care Read More BioXcel Therapeutics Planning to Submit sNDA This Month Seeking FDA Approval for At-Home Use of IGALMI®January 8, 2026 BioXcel Therapeutics Company remains focused on potential approval and launch of IGALMI® for the acute treatment of agitation…
MMental health Read More Biohaven Provides Update From Phase 2 Proof-of-Concept Study with BHV-7000 in Major Depressive DisorderDecember 24, 2025 NEW HAVEN, Conn., Dec. 24, 2025 /PRNewswire/ — Biohaven Ltd. (NYSE: BHVN) (“Biohaven”), a global clinical-stage biopharmaceutical company focused…
MMedication Read More Aptar’s Bidose Nasal System Delivers CARDAMYST™ (etripamil), the First and Only Self-Administered FDA-Approved Nasal Spray for Paroxysmal Supraventricular Tachycardia (PSVT)December 19, 2025 Milestone Pharmaceuticals received U.S. Food and Drug Administration approval of CARDAMYST for the conversion of acute symptomatic episodes…
MMarkets Read More High Growth Tech Stocks in Asia for October 2025October 13, 2025 As trade tensions between the U.S. and China reignite, impacting global markets, Asian tech stocks continue to capture…
GGenetics Read More Opus Genetics Appoints Rob Gagnon as Chief Financial OfficerSeptember 2, 2025 Opus Genetics, Inc. Robert Gagnon, CFO, Opus Genetics Robert Gagnon, CFO, Opus Genetics RESEARCH TRIANGLE PARK, N.C., Sept.…
MMarkets Read More Exploring High Growth Tech Stocks In The US MarketAugust 12, 2025 As the U.S. stock market navigates a period of volatility, with major indices like the Nasdaq retreating from…
MMarkets Read More 3 Asian Stocks Estimated To Be Up To 40.9% Below Intrinsic ValueAugust 1, 2025 As trade negotiations between major economies progress, Asian markets have shown resilience, with Chinese and Japanese indices posting…
MMarkets Read More MacroGenics And 2 Other Promising Penny Stocks To ConsiderJuly 14, 2025 Amid a backdrop of trade policy uncertainties and fluctuating market indices, the U.S. stock market remains near record…